So, lets again review the development in the last 2 1/2 weeks:
1. Jason Shin finalizes selling of his company for 10 million shares of MCCY and joins the team as vice president of research and development
2. Claude Lemay joins MCCY as their new president.
3. Last vestige of barriers to Audited Financials are cleared including succeeding in reporting status of the old shell, Telefficiency Holding Corporation under the Exchange Act and cancelling of 40 million shares of Raphael Huppe's own personal common stock to treasury optioning them to $0.70 to $1.50 per share.
4. Legal suit holding up the sales of MCCY is near resolution with declaration of bankruptsy of Biocognisafe.
5. Third party confirmation of FOLO product from one of the largest and respected motor freight company, Challenger Fleet, with their declaration of the existence of field testing of driver and vehicle performances in collaboration with ECT. In additions, reference a joint US/Canada fatigue management program.
6. eyewitness account of the finished FOLO CRAM product by one of the blogger (who is not a pumper or associated in any way with the company and high tech expert himself) declaring it is an "incredible device... absolutely floored" and that he has "never been this positive on this company" as he is now.
World class product now with world class management team.
What is now awaiting us in the next 2 1/2 weeks?
1. Audited financials imminent. All the barriers essentially removed.
2. Announcement of new CFO
3. Possible PR regarding the $300 million revenue
4. Beginning of aggressive marketing to number of clients in US
5. Completion of White Papers and presentation to Dept. of Transportation and insurance companies
AI
Market Data 
Markets 
